Tuberculosis expert recommends aggressive treatment for TB positive babies; Health Dept. doesn't specify treatment - KVIA.com
An infectious disease expert who's treated dozens of babies and children with Tuberculosis said the baby who tested positive for the infection should be immediately treated with at least three medications, hospitalized and given a spinal tap to ensure the infection has not traveled to the brain.
...
Dr. Gilbert Handal, a professor in the Department of Pediatrics Texas Tech University Health Sciences Center, said babies that young have not fully developed their lymph nodes which means doctors can't truly discern if the baby has active or latent TB once the babies test positive using a skin test. "If they become positive, you have to treat them like (active) TB, the treatment of TB is with four drugs," Handal said Monday.
Read the full story >>
Related Stories
Willed Body Memorial Service Honors Those Who Donated
On Memorial Day each May, a service is conducted at the Texas Tech University Health Sciences Center Institute of Anatomical Sciences to pay respect to the Willed Body Program donors and their families.
Molecular Pathology Preceptorship: Unmatched Value and Experience
Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.
Moseley Named Permian Basin Regional Dean of the Texas Tech University Health Sciences Center School of Nursing
Kelly Moseley, DHSc, R.N., has been named the TTUHSC School of Nursing regional dean in the Permian Basin.
Recent Stories
TTUHSC Researcher Receives National Award
The AACR presented its Minority-Serving Institution Faculty Scholar in Cancer Research Award to TTUHSC Associate Professor Duke Appiah, Ph.D., MPH, at the AACR 2025 Annual Meeting in Chicago recently.
TTUHSC Teams Selected for 2025 Innosphere Life Sciences Accelerator Cohort
A pair of teams representing TTUHSC earned a spot among the 33 startup groups selected for the 2025 cohort of the Innosphere Life Sciences Accelerator.
Exploring New Frontiers in Patient Care
Jenna Kesey, Ph.D., associate managing director for the Clinical Research Institute (CRI) at TTUHSC, said it's important that the university provides opportunities for its patients to have access to innovative therapies through the clinical trial process.